Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K.

J Clin Invest. 2012 Aug;122(8):2871-83. doi: 10.1172/JCI63539. Epub 2012 Jul 23.

2.

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.

Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao M, Tsou AP.

J Clin Invest. 2012 Aug;122(8):2884-97. doi: 10.1172/JCI63455. Epub 2012 Jul 23.

3.

miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.

El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI.

FEBS Lett. 2012 Sep 21;586(19):3309-16. doi: 10.1016/j.febslet.2012.06.054. Epub 2012 Jul 20.

4.

Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.

Tao J, Ji J, Li X, Ding N, Wu H, Liu Y, Wang XW, Calvisi DF, Song G, Chen X.

Oncotarget. 2015 Mar 30;6(9):6977-88.

5.

MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.

Cui M, Wang Y, Sun B, Xiao Z, Ye L, Zhang X.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):270-5. doi: 10.1016/j.bbrc.2014.01.051. Epub 2014 Jan 22.

PMID:
24462768
7.

MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.

Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, Jiang J.

Biochem Biophys Res Commun. 2012 Nov 30;428(4):525-31. doi: 10.1016/j.bbrc.2012.10.039. Epub 2012 Oct 12.

PMID:
23068095
8.

Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.

9.

TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.

Jiang S, Minter LC, Stratton SA, Yang P, Abbas HA, Akdemir ZC, Pant V, Post S, Gagea M, Lee RG, Lozano G, Barton MC.

J Hepatol. 2015 Feb;62(2):371-9. doi: 10.1016/j.jhep.2014.09.026. Epub 2014 Oct 2.

10.

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X.

J Biol Chem. 2011 Oct 21;286(42):36677-85. doi: 10.1074/jbc.M111.270561. Epub 2011 Aug 30.

11.

MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.

Liu S, Guo W, Shi J, Li N, Yu X, Xue J, Fu X, Chu K, Lu C, Zhao J, Xie D, Wu M, Cheng S, Liu S.

J Hepatol. 2012 Feb;56(2):389-96. doi: 10.1016/j.jhep.2011.08.008. Epub 2011 Aug 31.

PMID:
21888875
12.

FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.

Liu LL, Lu SX, Li M, Li LZ, Fu J, Hu W, Yang YZ, Luo RZ, Zhang CZ, Yun JP.

Oncotarget. 2014 Jul 15;5(13):5113-24.

13.

MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.

Lim L, Balakrishnan A, Huskey N, Jones KD, Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, Willenbring H, Dupuy A, Chen X, Brown D, Chang AN, Goga A.

Hepatology. 2014 Jan;59(1):202-15. doi: 10.1002/hep.26662. Epub 2013 Nov 22.

14.

Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.

Hsu SH, Yu B, Wang X, Lu Y, Schmidt CR, Lee RJ, Lee LJ, Jacob ST, Ghoshal K.

Nanomedicine. 2013 Nov;9(8):1169-80. doi: 10.1016/j.nano.2013.05.007. Epub 2013 May 30.

15.

Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.

Dong YW, Wang R, Cai QQ, Qi B, Wu W, Zhang YH, Wu XZ.

J Hepatol. 2014 Apr;60(4):792-801. doi: 10.1016/j.jhep.2013.12.004. Epub 2013 Dec 11.

PMID:
24333181
16.

MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.

Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.

J Hepatol. 2015 Oct;63(4):874-85. doi: 10.1016/j.jhep.2015.05.008. Epub 2015 May 18.

PMID:
25998163
17.

MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.

Zhang JG, Shi Y, Hong DF, Song M, Huang D, Wang CY, Zhao G.

Sci Rep. 2015 Jan 28;5:8087. doi: 10.1038/srep08087.

18.

Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.

Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, Gao Y, Zhang S, Lu Z, Ye L, Zhang X.

Neoplasia. 2013 Nov;15(11):1282-91.

19.

Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation.

Wagenaar TR, Zabludoff S, Ahn SM, Allerson C, Arlt H, Baffa R, Cao H, Davis S, Garcia-Echeverria C, Gaur R, Huang SM, Jiang L, Kim D, Metz-Weidmann C, Pavlicek A, Pollard J, Reeves J, Rocnik JL, Scheidler S, Shi C, Sun F, Tolstykh T, Weber W, Winter C, Yu E, Yu Q, Zheng G, Wiederschain D.

Mol Cancer Res. 2015 Jun;13(6):1009-21. doi: 10.1158/1541-7786.MCR-14-0703. Epub 2015 Mar 10.

20.

Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.

Cui M, Xiao Z, Sun B, Wang Y, Zheng M, Ye L, Zhang X.

Biochem Biophys Res Commun. 2014 Mar 14;445(3):651-5. doi: 10.1016/j.bbrc.2014.02.068. Epub 2014 Feb 24.

PMID:
24576478

Supplemental Content

Support Center